Assignee
VISION GLOBAL HOLDINGS LTD
HK·9 granted patents·1 pending application·15 citations·filing 2014–2020
Top patents by PatentIndex Score
10 records- 0187US10913770B2Mertansine polypeptide conjugatesVISION GLOBAL HOLDINGS LTD·Filed 2020·Granted Feb 9, 2021·2 cites·17 claims
- 0287US9255262B2Albumin-binding arginine deminase and the use thereofVISION GLOBAL HOLDINGS LTD·Filed 2014·Granted Feb 9, 2016·7 cites·19 claims
- 0376US9056098B2Hemoglobin-based oxygen carrier-containing pharmaceutical composition for cancer targeting treatment and prevention of cancer recurrenceVISION GLOBAL HOLDINGS LTD·Filed 2014·Granted Jun 16, 2015·3 cites·16 claims
- 0473US9803185B2Method for cancer targeting treatment and detection of arginine using albumin-binding arginine deiminase fusion proteinVISION GLOBAL HOLDINGS LTD·Filed 2015·Granted Oct 31, 2017·1 cites·14 claims
- 0573US9636404B2Pharmaceutical composition comprising modified hemoglobin-based therapeutic agent for cancer targeting treatment and diagnostic imagingVISION GLOBAL HOLDINGS LTD·Filed 2014·Granted May 2, 2017·2 cites·20 claims
- 0661USRE47233EAlbumin-binding arginine deiminase and the use thereofVISION GLOBAL HOLDINGS LTD·Filed 2017·Granted Feb 12, 2019·0 cites·19 claims
- 0755US10946099B2Compositions for photodynamic therapy and fluorescence diagnosis of cancers and other diseasesVISION GLOBAL HOLDINGS LTD·Filed 2018·Granted Mar 16, 2021·0 cites·13 claims
- 0850US2021401952A1Method of treating AML subtypes using arginine-depleting agentsVISION GLOBAL HOLDINGS LTD·Filed 2020·Application pending·0 cites
- 0949US10322180B2Pharmaceutical composition comprising modified hemoglobin-based therapeutic agent for cancer targeting treatment and diagnostic imagingVISION GLOBAL HOLDINGS LTD·Filed 2017·Granted Jun 18, 2019·0 cites·4 claims
- 1048USRE48805EMethod for cancer targeting treatment and detection of arginine using albumin-binding arginine deiminase fusion proteinVISION GLOBAL HOLDINGS LTD·Filed 2019·Granted Nov 2, 2021·0 cites·14 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →